HomeNewsBusinessMarketsMankind Pharma gains on raising stake in British therapeutics firm

Mankind Pharma gains on raising stake in British therapeutics firm

For Mankind, this is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis, and other muscle-wasting disorders.

December 18, 2023 / 11:43 IST
Story continues below Advertisement
Shares of the company have risen 12.32 percent over the past six months.
Shares of the company have risen 12.32 percent over the past six months.

Mankind Pharma shares traded with 1 percent gains on December 18 after the pharma player raised its holding in the UK-based Actimed Therapeutics by purchasing a stake of 1.29 percent for a total consideration of £999,900.

Following the acquisition, Mankind Pharma held 10.19 percent of Actimed Therapeutics shares. For Mankind, this is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis, and other muscle-wasting disorders.

Story continues below Advertisement

As of 11.20am, shares of the company were quoting Rs 1,909.25 apiece on the BSE, higher by 1.2 percent from the previous session’s closing price.

On December 12, private equity firm Chrys Capital sold Rs 3,282 crore worth of shares in Mankind Pharma through a block deal executed on the stock exchanges.